Target intelligence / Profile preview

Cell signaling modulator

Molecular classification
Enzyme, Receptor, Transcription factor, Protein kinase, Phosphatase, Other
01

Overview

A cell signaling modulator is a broad functional classification referring to a diverse group of proteins that regulate the transmission of biochemical information within and between cells. These modulators include receptors, protein kinases, phosphatases, and transcription factors that participate in complex cascades such as the JAK/STAT, PI3K/Akt/mTOR, and MAPK/ERK pathways (Nature Education, 2014; NCI Dictionary, 2023). By controlling how cells respond to external stimuli like hormones or cytokines, these proteins dictate fundamental processes including growth, immune activation, and programmed cell death. Dysregulation of signaling modulators is a primary driver in many pathologies; for example, overactive kinase signaling is frequently implicated in oncogenesis, while aberrant cytokine signaling underpins many chronic inflammatory and autoimmune diseases (PubMed, PMC4961358). Consequently, drugs designed to modulate these pathways—such as kinase inhibitors and monoclonal antibodies—are essential in modern oncology, dermatology, and rheumatology. However, because 'cell signaling modulator' identifies a therapeutic category rather than a specific molecular entity, it is considered too broad for precise target identification in drug discovery.

Other names
Signal transduction modulatorSignaling pathway modulatorCellular signaling regulatorIntracellular signaling modulator
02

Mechanism of action

Modulation (inhibition or activation) of specific intracellular signaling cascades to restore homeostatic function or block pathological cellular responses.

03

Biological functions

Signal transductionCell proliferationCell cycleApoptosisImmune responseCell differentiationMetabolic regulation
04

Disease associations

CancerInflammationAutoimmune diseaseNeurodegenerative diseaseCardiovascular diseasePsoriasisRheumatoid arthritis
05

Safety considerations

Immunosuppression and increased risk of infectionHematological toxicities (e.g., anemia, neutropenia)Off-target kinase inhibitionMetabolic disturbances (e.g., hyperlipidemia)Risk of secondary malignanciesDisruption of normal homeostatic cell signaling
06

Interacting drugs

6 more in the full profile.

07

Biomarkers

Phosphorylated protein levels (e.g., p-STAT, p-AKT, p-ERK)Cytokine expression profiles (e.g., IL-6, TNF-alpha)Gene expression signatures (RNA-seq)Protein-protein interaction assays

Beyond the preview

Go deeper on Cell signaling modulator.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cell signaling modulator.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call